The use of high performance liquid chromatography to speciate and characterize the epidemiology of mycobacteria

Laboratory Medicine

Volumn 42, Issue 10, 2011, Pages 612-617

  Jeong, Joseph ^a   Kim, Sung Ryul ^a   Lee, Seon Ho ^a   Lim, Ji Hun ^a   Choi, Jung In ^a   Park, Jae Sun ^a   Chang, Chulhun L ^b   Choi, Jun Yong ^c   Richman, Douglas D ^d,e,f   Smith, Davey M ^d,f  

^a University of Ulsan College of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Hplc; Mycobacteria; Mycobacterium tuberculosis; Nontuberculous mycobacteria

Indexed keywords

MYCOLIC ACID;

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM PEREGRINUM; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM SIMIAE; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TERRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM XENOPEI; NONHUMAN; NONTUBERCULOUS MYCOBACTERIA; SOUTH KOREA;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 81455140016     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMDDEHPSYE6ZDM3C     Document Type: Article

References (39)

1. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med. 1997;156(2 Pt 2):S1-S25.
2. Burman WJ, Reves RR. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis. 2000;31:1390-1395.
3. Butler WR, Floyd MM, Silcox V, et al. Standardized method for HPLC identification of mycobacteria. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA. 1996.
4. Butler WR, Floyd MM, Silcox V, et al. Mycolic acid pattern standards for HPLC identification of mycobacteria. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA. 1999.
5. Butler WR, Jost KC Jr, Kilburn JO. Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol. 1991;29:2468-2472.
6. Butler WR, Guthertz LS. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev. 2001;14:704-726.
7. Centers for Disease Control and Prevention. Nontuberculous mycobacteria reported to the public health laboratory information system by state public health laboratories United States, 1993-6. Centers for Disease Control and Prevention, Atlanta, GA. 1999.
8. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-1021.
9. Daley CL. Nontuberculous mycobacterial disease in transplant recipients: Early diagnosis and treatment. Curr Opin Organ Transplant. 2009;14:619-624.
10. Euzéby JP. List of bacterial names with standing in nomenclature, 1998. Society for Systematic and Veterinary Bacteriology, London. 2002.
11. Falkinham JO 3rd. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev. 1996;9:177-215.
12. Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest. 2006;129:1653-1672.
13. Hoffner SE. Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria. Eur J Clin Microbiol Infect Dis. 1994;13:937-941.
14. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:1332-1338.
15. Jeong J, Lee SH, Jeong US, et al. [Identification of mycobacteria using high performance liquid chromatography in clinical specimens.] [Korean] Korean J Clin Microbiol. 2004;7:148-155.
16. Kim BJ, Hong SK, Lee KH, et al. Differential identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria by duplex PCR assay using the RNA polymerase gene (rpoB). J Clin Microbiol. 2004;42:1308-1312.
17. Kim KS, Shin YD, Ahn JW. Epidermiologic study of unclassified mycobacteria. Tuberc Respir Dis. 1966;13:5-20.
18. Kim SC, Kim SC. A study on unclassified mycobacteria isolated from human sputa. Tuberc Respir Dis. 1970;17:33-42.
19. Koh WJ, Kwon OJ, Jeon K, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006;129:341-348.
20. Lee SK, Shin YD. 1967. Epidermiologic study of atypical mycobacterial infection. Tuberc Respir Dis. 1967;14:12-38.
21. Mori T. [Atypical mycobacteriosis]. [Japanese] Nihon Rinsho. 2001;59(suppl 7):197-204.
22. Nah J, Huh JW, Lee SH, et al. [Identification of Mycobacterium tuberculosis complex using a gene probe method.[[Korean] Korean J Lab Med. 1997;17:71-78.
23. CLSI. Molecular Diagnostic Methods for Infectious Diseases; Proposed Guideline, 2nd ed. MM3-P2. Wayne, PA: CLSI; 2005.
24. Noordhoek GT, van Embden JD, Kolk AH. Questionable reliability of the polymerase chain reaction in the detection of Mycobacterium tuberculosis. N Engl J Med. 1993;329:2036.
25. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987;135:1007-1014.
26. Olivier KN. Nontuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med. 1998;4:148-153.
27. Park CM, Heo SR, Park KU, et al. [Isolation of nontuberculous mycobacteria using polymerase chain reaction-restriction fragment length polymorphism.] [Korean] Korean J Lab Med. 2006;26:161-167.
28. Phillips MS, von Reyn CF. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis. 2001;33:1363-1374.
29. Piersimoni C, Scarparo C. Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerg Infect Dis. 2009;15:1351-1358.
30. Primm TP, Lucero CA, Falkinham JO 3rd. Health impacts of environmental mycobacteria. Clin Microbiol Rev. 2004;17:98-106.
31. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989;321:863-868.
32. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995;273:220-226.
33. Reisner BS, Gatson AM, Woods GL. Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures. J Clin Microbiol. 1994;32:2995-2998.
34. Scientific Committee in Korean Academy of Tuberculosis and Respiratory Diseases. National survey of mycobacterial diseases other than tuberculosis in Korea. Tuberc Respir Dis. 1995;42:277-294.
35. Tortoli E, Bartoloni A, Böttger EC, et al. Burden of unidentifiable mycobacteria in a reference laboratory. J Clin Microbiol. 2001;39:4058-4065.
36. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979;119:107-159.
37. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2002. Geneva, Switzerland, WHO/CDS/TB/2002.295.
38. World Health Organization. Strategic Framework to Decrease the Burden of TB/HIV. 2002. Geneva, Switzerland, WHO/CDS/TB/2002.296, WHO/HIV_AIDS/02.2.
39. Yim JJ, Park YK, Lew WJ, et al. Mycobacterium kansasii pulmonary diseases in Korea. J Korean Med Sci. 2005;20:957-960.